NewAmsterdam Pharma Company
NAMS
#4041
Rank
ยฃ1.82 B
Marketcap
ยฃ19.73
Share price
-0.28%
Change (1 day)
146.42%
Change (1 year)

Revenue for NewAmsterdam Pharma Company (NAMS)

Revenue in 2024 (TTM): ยฃ11.23 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is ยฃ11.11 Million. In 2023 the company made a revenue of ยฃ11.16 Million a decrease over the revenue in the year 2022 that were of ยฃ87.28 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NewAmsterdam Pharma Company from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ11.23 M0.66%
2023 ยฃ11.16 M-87.21%
2022ยฃ87.28 M
2021N/A
2020N/A